These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy. Sonnenschein K; Fiedler J; de Gonzalo-Calvo D; Xiao K; Pfanne A; Just A; Zwadlo C; Soltani S; Bavendiek U; Kraft T; Dos Remedios C; Cebotari S; Bauersachs J; Thum T Sci Rep; 2021 Jan; 11(1):1755. PubMed ID: 33469076 [TBL] [Abstract][Full Text] [Related]
8. A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy. Thottakara T; Lund N; Krämer E; Kirchhof P; Carrier L; Patten M Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827715 [TBL] [Abstract][Full Text] [Related]
9. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916 [TBL] [Abstract][Full Text] [Related]
10. Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young. Fernlund E; Gyllenhammar T; Jablonowski R; Carlsson M; Larsson A; Ärnlöv J; Liuba P Pediatr Cardiol; 2017 Apr; 38(4):853-863. PubMed ID: 28361263 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of new predictive scores for sudden cardiac death in childhood hypertrophic cardiomyopathy in a French cohort. Fontanges PA; Marquie C; Houeijeh A; Baudelet JB; Richard A; Amenyah C; Lucidarme S; Bonnet M; Delarue A; Bichali S; Assi NA; Marechaux S; Menet A; Vaksmann G; Godart F; Domanski O Arch Cardiovasc Dis; 2024; 117(6-7):402-408. PubMed ID: 38821762 [TBL] [Abstract][Full Text] [Related]
13. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy. Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809 [TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts. Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862 [TBL] [Abstract][Full Text] [Related]
15. Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis. Jansen M; Algül S; Bosman LP; Michels M; van der Velden J; de Boer RA; van Tintelen JP; Asselbergs FW; Baas AF ESC Heart Fail; 2022 Oct; 9(5):3418-3434. PubMed ID: 35842920 [TBL] [Abstract][Full Text] [Related]
16. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy. Norrish G; Qu C; Field E; Cervi E; Khraiche D; Klaassen S; Ojala TH; Sinagra G; Yamazawa H; Marrone C; Popoiu A; Centeno F; Schouvey S; Olivotto I; Day SM; Colan S; Rossano J; Wittekind SG; Saberi S; Russell M; Helms A; Ingles J; Semsarian C; Elliott PM; Ho CY; Omar RZ; Kaski JP Eur J Prev Cardiol; 2022 Mar; 29(4):678-686. PubMed ID: 34718528 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience. Tunca Sahin G; Ozgur S; Kafali HC; Sevinc Sengul F; Haydin S; Guzeltas A; Ergul Y Pediatr Int; 2021 Jan; 63(1):37-45. PubMed ID: 32682351 [TBL] [Abstract][Full Text] [Related]
19. Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) study. Zhu A; Bews H; Cheung D; Nagalingam RS; Mittal I; Goyal V; Asselin CY; Kirkpatrick IDC; Czubryt MP; Jassal DS Can J Physiol Pharmacol; 2020 Jul; 98(7):459-465. PubMed ID: 32027517 [TBL] [Abstract][Full Text] [Related]
20. Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014). Hładij R; Rajtar-Salwa R; Dimitrow PP Cardiovasc Ultrasound; 2017 Sep; 15(1):24. PubMed ID: 28903763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]